Liquidia (LQDA) EBT Margin (QoQ) (2021 - 2026)
Liquidia (LQDA) EBT Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - |
| 10 | Liquidia | 6.98 Bn | 6.76 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,692.00 |
| Dec 31, 2025 | 2,232.00 |
| Sep 30, 2025 | 46,401.00 |
| Jun 30, 2025 | 75,920.00 |
| Mar 31, 2025 | 9,048.00 |
| Dec 31, 2024 | -62,258.00 |
| Sep 30, 2024 | 8,588.00 |
| Jun 30, 2024 | 22,872.00 |
| Mar 31, 2024 | -40,639.00 |
| Dec 31, 2023 | -17,652.00 |
| Sep 30, 2023 | 6,206.00 |
| Jun 30, 2023 | -28,140.00 |
| Mar 31, 2023 | -8,809.00 |
| Dec 31, 2022 | 16,538.00 |
| Sep 30, 2022 | -4,615.00 |
| Jun 30, 2022 | 18,689.00 |
| Mar 31, 2022 | -6,835.00 |
| Dec 31, 2021 | -13,062.00 |
| Sep 30, 2021 | -3,496.00 |
| Jun 30, 2021 | 10,197.00 |